Epigenome-Guided Analysis of the Transcriptome of Plaque Macrophages during Atherosclerosis Regression Reveals Activation of the Wnt Signaling Pathway

PLoS Genetics

Volumn 10, Issue 12, 2014, Pages

  Ramsey, Stephen A ^a   Vengrenyuk, Yuliya ^b   Menon, Prashanthi ^b   Podolsky, Irina ^c   Feig, Jonathan E ^b   Aderem, Alan ^c   Fisher, Edward A ^b   Gold, Elizabeth S ^c  

^a Oregon State University   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; T CELL SPECIFIC HMG BOX FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SOX; UNCLASSIFIED DRUG; WNT PROTEIN; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN RECEPTOR; TRANSCRIPTOME;

5' REGULATORY REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CELL MOTILITY; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSRC1 GENE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; GENOME; KNOCKOUT MOUSE; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; REMISSION;

ANIMALS; CELLS, CULTURED; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENOME; HYPOLIPIDEMIC AGENTS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; REMISSION INDUCTION; TRANSCRIPTOME; WNT SIGNALING PATHWAY;

EID: 84919624821     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004828     Document Type: Article

References (126)

1. Alwan A, Armstrong T, Bettcher D, Boerma T, Branca F, et al. (2011) Global Atlas on Cardiovascular Diseases Prevention and Control. Mendes S, Puska P, Norrving B, editors Geneva: World Health Organization.
2. Oliva A, Flores J, Merigioli S, LeDuc L, Benito B, et al. (2011) Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents. Atherosclerosis 218: 28–32 doi:10.1016/j.atherosclerosis.2011.05.012
3. McGill HC, McMahan CA, Gidding SS, (2008) Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117: 1216–1227 doi:10.1161/CIRCULATIONAHA.107.717033
4. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–1847 doi:10.1161/01.CIR.97.18.1837
5. Reardon MF, Nestel PJ, Craig IH, Harper RW, (1985) Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71: 881–888 doi:10.1161/01.CIR.71.5.881
6. Williams KJ, Feig JE, Fisher EA, (2008) Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med 5: 91–102 doi:10.1038/ncpcardio1086
7. Francis AA, Pierce GN, (2011) An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. Exp Clin Cardiol 16: 77–86.
8. Hewing B, Fisher EA, (2012) Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis. Expert Opin Drug Discov 7: 207–216 doi:10.1517/17460441.2012.660143
9. Hansson GK, Hermansson A, (2011) The immune system in atherosclerosis. Nat Immunol 12: 204–212 doi:10.1038/ni.2001
10. Moore KJ, Tabas I, (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341–355.
11. Li AC, Glass CK, (2002) The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235–1242 doi:10.1038/nm1102-1235
12. Ross R, (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340: 115–126 doi:10.1056/NEJM199901143400207
13. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, et al. (1995) Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565–1569.
14. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, et al. (1996) Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7: 330–335.
15. Daoud AS, Fritz KE, Jarmolych J, Frank AS, (1985) Role of macrophages in regression of atherosclerosis. Ann N Y Acad Sci 454: 101–114.
16. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, et al. (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100: 1816–1822 doi:10.1161/01.CIR.100.17.1816
17. Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, et al. (2011) Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe−/− mice during disease regression. J Clin Invest 121: 2025–2036 doi:10.1172/JCI43802
18. Raffai RL, Weisgraber KH, (2002) Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biochem 277: 11064–11068 doi:10.1074/jbc.M111222200
19. Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, et al. (2003) Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107: 1315–1321.
20. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, et al. (2011) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123: 989–998 doi:10.1161/CIRCULATIONAHA.110.984146
21. Trogan E, Fayad ZA, Itskovich VV, Aguinaldo J-GS, Mani V, et al. (2004) Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol 24: 1714–1719 doi:10.1161/01.ATV.0000139313.69015.1c
22. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101: 11779–11784 doi:10.1073/pnas.0403259101
23. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A 103: 3781–3786 doi:10.1073/pnas.0511043103
24. Feig JE, Shang Y, Rotllan N, Vengrenyuk Y, Wu C, et al. (2011) Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS ONE 6: e28534 doi:10.1371/journal.pone.0028534
25. Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O, (2006) Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 187: 40–49 doi:10.1016/j.atherosclerosis.2005.08.024
26. Hewing B, Parathath S, Mai CK, Fiel MI, Guo L, et al. (2013) Rapid regression of atherosclerosis with MTP inhibitor treatment. Atherosclerosis 227: 125–129 doi:10.1016/j.atherosclerosis.2012.12.026
27. Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, et al. (2001) High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Potential implications for acute plaque stabilization. Circulation 103: 3047–3050 doi:10.1161/hc2501.092494
28. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, et al. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proceedings of the National Academy of Sciences 108: 7166–7171 doi:10.1073/pnas.1016086108
29. Skogsberg J, Lundstrom J, Kovacs A, Nilsson R, Noori P, et al. (2008) Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet 4: e1000036 doi:10.1371/journal.pgen.1000036
30. Björkegren JLM, Hägg S, Talukdar HA, Foroughi Asl H, Jain RK, et al. (2014) Plasma cholesterol–induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. PLoS Genet 10: e1004201 doi:10.1371/journal.pgen.1004201.s019
31. Chereshnev I, Trogan E, Omerhodzic S, Itskovich V, Aguinaldo J-G, et al. (2003) Mouse model of heterotopic aortic arch transplantation. J Surg Res 111: 171–176 doi:10.1016/S0022-4804(03)00039-8
32. Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, et al. (1998) Lipoprotein clearance mechanisms in LDL receptor-deficient “Apo-B48-only” and “Apo-B100-only” mice. J Clin Invest 102: 1559–1568 doi:10.1172/JCI4164
33. Véniant MM, Sullivan MA, Kim SK, Ambroziak P, Chu A, et al. (2000) Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. J Clin Invest 106: 1501–1510 doi:10.1172/JCI10695
34. Raabe M, Véniant MM, Sullivan MA, Zlot CH, Bjorkegren J, et al. (1999) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103: 1287–1298 doi:10.1172/JCI6576
35. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343–353.
36. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, et al. (2012) Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS ONE 7: e39790 doi:10.1371/journal.pone.0039790.t001
37. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303–7311.
38. Vettese-Dadey M, Grant PA, Hebbes TR, Crane- Robinson C, Allis CD, et al. (1996) Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J 15: 2508–2518.
39. Ramsey SA, Knijnenburg TA, Kennedy KA, Zak DE, Gilchrist M, et al. (2010) Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites. Bioinformatics 26: 2071–2075 doi:10.1093/bioinformatics/btq405
40. Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG, et al. (2011) Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res 21: 1757–1767 doi:10.1101/gr.121541.111
41. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810 doi:10.1146/annurev.cellbio.20.010403.113126
42. Mosimann C, Hausmann G, Basler K, (2009) Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10: 276–286 doi:10.1038/nrm2654
43. Pereira CP, Bachli EB, Schoedon G, (2009) The Wnt pathway: a macrophage effector molecule that triggers inflammation. Curr Atheroscler Rep 11: 236–242.
44. Amini-Nik S, Cambridge E, Yu W, Guo A, Whetstone H, et al. (2014) β-Catenin-regulated myeloid cell adhesion and migration determine wound healing. J Clin Invest 124: 2599–2610 doi:10.1172/JCI62059
45. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, et al. (2002) Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 99: 2234–2239 doi:10.1073/pnas.042683999
46. Trogan E, Fisher EA, (2005) Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions. Methods Mol Biol 293: 221–231.
47. English SB, Butte AJ, (2007) Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes. Bioinformatics 23: 2910–2917 doi:10.1093/bioinformatics/btm483
48. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond–the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5: e10693 doi:10.1371/journal.pone.0010693.t007
49. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, et al. (2012) Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 44: 502–510 doi:10.1038/ng.2205
50. Abecasis GR, Auton A, Brooks LD, DePristo MA, Genomes Project Consortium (2012) et al. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56–65 doi:10.1038/nature11632
51. Ramos EM, Hoffman D, Junkins HA, Maglott D, Phan L, et al. (2014) Phenotype-Genotype Integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources. Eur J Hum Genet 22: 144–147 doi:10.1038/ejhg.2013.96
52. Kleber ME, Renner W, Grammer TB, Linsel-Nitschke P, Boehm BO, et al. (2010) Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 209: 492–497 doi:10.1016/j.atherosclerosis.2009.09.068
53. Zhou L, Ding H, Zhang X, He M, Huang S, et al. (2011) Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population. PLoS ONE 6: e27481 doi:10.1371/journal.pone.0027481
54. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443–453 doi:10.1056/NEJMoa072366
55. Samani NJ, Deloukas P, Erdmann J, Hengstenberg C, Coronary Artery Disease Consortium (2009) et al. (2009) Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol 29: 774–780 doi:10.1161/ATVBAHA.108.181388
56. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, et al. (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466: 714–719 doi:10.1038/nature09266
57. Kjolby M, Andersen OM, Breiderhoff T, Fjorback AW, Pedersen KM, et al. (2010) Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 12: 213–223 doi:10.1016/j.cmet.2010.08.006
58. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, et al. (2012) A map of the cis-regulatory sequences in the mouse genome. Nature 488: 116–120 doi:10.1038/nature11243
59. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q, (2008) GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 9 Suppl 1: S4 doi:10.1186/gb-2008-9-s1-s4
60. Stumpf M, Balding DJ, Girolami M (2011) Handbook of Statistical Systems Biology. First ed. West Sussex: John W. Wiley & Sons.
61. Gabdoulline R, Eckweiler D, Kel A, Stegmaier P, (2012) 3DTF: a web server for predicting transcription factor PWMs using 3D structure-based energy calculations. Nucleic Acids Research 40: W180–W185 doi:10.1093/nar/gks551
62. Tsaousi A, Mill C, George SJ, (2011) The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol 22: 350–357 doi:10.1097/MOL.0b013e32834aa701
63. Mermelstein CS, Portilho DM, Mendes FA, Costa ML, Abreu JG, (2007) Wnt/beta-catenin pathway activation and myogenic differentiation are induced by cholesterol depletion. Differentiation 75: 184–192 doi:10.1111/j.1432-0436.2006.00129.x
64. Kormish JD, Sinner D, Zorn AM, (2010) Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn 239: 56–68 doi:10.1002/dvdy.22046
65. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Research 40: W498–W504 doi:10.1093/nar/gks494
66. Mani A, Radhakrishnan J, Wang H, Mani A, Mani M-A, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278–1282 doi:10.1126/science.1136370
67. van der Heyden MA, Rook MB, Hermans MM, Rijksen G, Boonstra J, et al. (1998) Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci 111 (Pt 12) 1741–1749.
68. Todaro GJ, Lazar GK, Green H, (1965) The initiation of cell division in a contact-inhibited mammalian cell line. J Cell Physiol 66: 325–333.
69. Koth LL, Cambier CJ, Ellwanger A, Solon M, Hou L, et al. (2010) DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2. J Immunol 184: 6522–6528 doi:10.4049/jimmunol.0901171
70. Gold ES, Ramsey SA, Sartain MJ, Selinummi J, Podolsky I, et al. (2012) ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med 209: 807–817 doi:10.1084/jem.20111202
71. Ramsey SA, Gold ES, Aderem A, (2010) A systems biology approach to understanding atherosclerosis. EMBO Mol Med 2: 79–89 doi:10.1002/emmm.201000063
72. Brasier AR, (2010) The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86: 211–218 doi:10.1093/cvr/cvq076
73. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, et al. (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85: e17–e24.
74. Virmani R, Burke AP, Farb A, Kolodgie FD, (2002) Pathology of the unstable plaque. Prog Cardiovasc Dis 44: 349–356.
75. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, et al. (2000) Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 157: 1259–1268 doi:10.1016/S0002-9440(10)64641-X
76. Laufer EM, Winkens MHM, Narula J, Hofstra L, (2009) Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Arterioscler Thromb Vasc Biol 29: 1031–1038 doi:10.1161/ATVBAHA.108.165522
77. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, et al. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114: 1564–1576 doi:10.1172/JCI18730
78. Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I, (2007) Pioglitazone Increases Macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor null mice. Circulation 116: 2182–2190 doi:10.1161/CIRCULATIONAHA.107.698852
79. Nakaya H, Summers BD, Nicholson AC, Gotto AM, Hajjar DP, et al. (2009) Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol 174: 2007–2014 doi:10.2353/ajpath.2009.080611
80. Gong K, Zhou F, Huang H, Gong Y, Zhang L, (2012) Suppression of GSK3β by ERK mediates lipopolysaccharide induced cell migration in macrophage through β-catenin signaling. Protein Cell 3: 762–768 doi:10.1007/s13238-012-2058-x
81. van Gils JM, Derby MC, Fernandes LR, Ramkhelawon B, Ray TD, et al. (2012) The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 13: 136–143 doi:10.1038/ni.2205
82. Sarzani R, Salvi F, Bordicchia M, Guerra F, Battistoni I, et al. (2011) Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. Nutr Metab Cardiovasc Dis 21: 150–156 doi:10.1016/j.numecd.2009.08.004
83. Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, et al. (2010) Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J 24: 4599–4612 doi:10.1096/fj.10-160994
84. Marinou K, Christodoulides C, Antoniades C, Koutsilieris M, (2012) Wnt signaling in cardiovascular physiology. Trends Endocrinol Metab 23: 628–636 doi:10.1016/j.tem.2012.06.001
85. Terrand J, Bruban V, Zhou L, Gong W, Asmar El Z, et al. (2009) LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J Biochem 284: 381–388 doi:10.1074/jbc.M806538200
86. Go G-W, Srivastava R, Hernandez-Ono A, Gang G, Smith SB, et al. (2014) The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metab 19: 209–220 doi:10.1016/j.cmet.2013.11.023
87. Fujino T, Asaba H, Kang M-J, Ikeda Y, Sone H, et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci USA 100: 229–234 doi:10.1073/pnas.0133792100
88. Hock MB, Kralli A, (2009) Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 71: 177–203 doi:10.1146/annurev.physiol.010908.163119
89. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, et al. (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609–616 doi:10.1161/01.RES.0000119171.44657.45
90. Puig O, Yuan J, Stepaniants S, Zieba R, Zycband E, et al. (2011) A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status. Circ Cardiovasc Genet 4: 595–604 doi:10.1161/CIRCGENETICS.111.960773
91. Hsieh P-C, Chiang M-L, Chang J-C, Yan Y-T, Wang F-F, et al. (2012) DDA3 stabilizes microtubules and suppresses neurite formation. J Cell Sci 125: 3402–3411 doi:10.1242/jcs.099150
92. Zhang L, Shao H, Zhu T, Xia P, Wang Z, et al. (2013) DDA3 associates with microtubule plus ends and orchestrates microtubule dynamics and directional cell migration. Sci Rep 3: 1681 doi:10.1038/srep01681
93. Hsieh P-C, Chang J-C, Sun W-T, Hsieh S-C, Wang M-C, et al. (2007) p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway. Oncogene 26: 4928–4940 doi:10.1038/sj.onc.1210304
94. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291: 1071–1080 doi:10.1001/jama.291.9.1071
95. Zhao XQ, Brown BG, Hillger L, Sacco D, Bisson B, et al. (1993) Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B. Circulation 88: 2744–2753 doi:10.1161/01.CIR.88.6.2744
96. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195–2207 doi:10.1056/NEJMoa0807646
97. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, et al. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295: 1556–1565 doi:10.1001/jama.295.13.jpc60002
98. Parathath S, Grauer L, Huang L-S, Sanson M, Distel E, et al. (2011) Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 60: 1759–1769 doi:10.2337/db10-0778
99. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
100. Cho HJ, Shashkin P, Gleissner CA, Dunson D, Jain N, et al. (2007) Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics 29: 149–160 doi:10.1152/physiolgenomics.00051.2006
101. Hägg DA, Jernas M, Wiklund O, Thelle DS, Fagerberg B, et al. (2008) Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes. Int J Mol Med 21: 697–704.
102. Bolstad BM (2004) Low-level analysis of high-density oligonucleotide array data: background, normalization, and summarization. Ph.D. Thesis, Berkeley: University of California, Berkeley.
103. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289–300.
104. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175 doi:10.1093/nar/gni179
105. Affymetrix (2006) Identifying and validating alternative splicing events. Affymetrix Technical Note
106. Okoniewski MJ, Miller CJ, (2008) Comprehensive analysis of Affymetrix exon arrays using BioConductor. PLoS Comput Biol 4: e6 doi:10.1371/journal.pcbi.0040006
107. Smyth GK, (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3 doi:10.2202/1544-6115.1027
108. Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4: P3.
109. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550 doi:10.1073/pnas.0506580102
110. Litvak V, Ratushny AV, Lampano AE, Schmitz F, Huang AC, et al. (2012) A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature doi:10.1038/nature11428
111. Affymetrix (2005) Guide to probe logarithmic intensity error (PLIER) estimation. Affymetrix Technical Note
112. Affymetrix (2005) Exon array background correction. First ed. Affymetrix Whitepaper.
113. Dabney A, Storey JD, (2003) QVALUE: the manual version 1.0. Computer Software User Guide, University of Washington, Department of Biostatistics
114. Breiman L, (2001) Random forests. Machine learning 45: 5–32.
115. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034–1050 doi:10.1101/gr.3715005
116. Wu H, Caffo B, Jaffee HA, Irizarry RA, Feinberg AP, (2010) Redefining CpG islands using hidden Markov models. Biostatistics 11: 499–514 doi:10.1093/biostatistics/kxq005
117. Wingender E, Chen X, Hehl R, Karas H, Liebich I, et al. (2000) TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 28: 316–319.
118. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, et al. (2010) JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 38: D105–D110 doi:10.1093/nar/gkp950
119. Frith MC, Fu Y, Yu L, Chen J-F, Hansen U, et al. (2004) Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 32: 1372–1381 doi:10.1093/nar/gkh299
120. Nishida K, Frith MC, Nakai K, (2009) Pseudocounts for transcription factor binding sites. Nucleic Acids Research 37: 939–944 doi:10.1093/nar/gkn1019
121. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498–2504 doi:10.1101/gr.1239303
122. Wu X, Watson M, (2009) CORNA: testing gene lists for regulation by microRNAs. Bioinformatics 25: 832–833 doi:10.1093/bioinformatics/btp059
123. Smedley D, Haider S, Ballester B, Holland R, London D, et al. (2009) BioMart–biological queries made easy. BMC Genomics 10: 22 doi:10.1186/1471-2164-10-22
124. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG, (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28: 771–776 doi:10.1093/bioinformatics/bts043
125. Remm M, Storm CE, Sonnhammer EL, (2001) Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J Mol Biol 314: 1041–1052 doi:10.1006/jmbi.2000.5197
126. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938–2939 doi:10.1093/bioinformatics/btn564